Canada Markets close in 25 mins

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
76.73+0.95 (+1.25%)
As of 3:35PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 547.71B
Enterprise Value 346.64B
Trailing P/E 65.19
Forward P/E 135.36
PEG Ratio (5 yr expected) 13.51
Price/Sales (ttm)11.04
Price/Book (mrq)12.42
Enterprise Value/Revenue 310.79
Enterprise Value/EBITDA 634.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 35.30%
S&P500 52-Week Change 3N/A
52 Week High 382.55
52 Week Low 351.51
50-Day Moving Average 373.08
200-Day Moving Average 371.37

Share Statistics

Avg Vol (3 month) 32.97M
Avg Vol (10 day) 31.74M
Shares Outstanding 5621.74M
Float 615.88M
% Held by Insiders 10.67%
% Held by Institutions 189.06%
Shares Short (Jul. 14, 2020) 47.36M
Short Ratio (Jul. 14, 2020) 42.52
Short % of Float (Jul. 14, 2020) 41.20%
Short % of Shares Outstanding (Jul. 14, 2020) 41.18%
Shares Short (prior month Jun. 14, 2020) 47.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3May 31, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 17.21%
Operating Margin (ttm)28.85%

Management Effectiveness

Return on Assets (ttm)12.99%
Return on Equity (ttm)20.26%

Income Statement

Revenue (ttm)4.32B
Revenue Per Share (ttm)6.93
Quarterly Revenue Growth (yoy)-14.90%
Gross Profit (ttm)3.23B
Net Income Avi to Common (ttm)743.6M
Diluted EPS (ttm)1.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.16B
Total Cash Per Share (mrq)1.87
Total Debt (mrq)684.5M
Total Debt/Equity (mrq)17.83
Current Ratio (mrq)3.08
Book Value Per Share (mrq)6.18

Cash Flow Statement

Operating Cash Flow (ttm)1.27B
Levered Free Cash Flow (ttm)681.15M